Global English
- Austria Deutsch
- Belgium Nederlands Français
- Brazil Português
- Canada Français English
- France Français
- Germany Deutsch
- Ireland English
- Italy Italiano
- Japan 日本語
- Luxembourg Français Deutsch
- Netherlands Nederlands
- Portugal Português
- Spain Español
- Switzerland Français Deutsch Italiano
- Taiwan 繁體中文
- United Kingdom English

siRNA

Alnylam Norton Manufacturing Facility

December 17, 2025 Alnylam Announces Major Expansion of U.S. Pharmaceutical Manufacturing Facility $250 million investment will add new capacity and siRNA enzymatic ligation capabilities to Alnylam's Norton, Massachusetts site Read More ›

Alnylam Making Our Medicines

September 30, 2025 How Alnylam’s Manufacturing Investments Bring RNAi Therapeutics to More Patients, Faster Translating our pioneering work in RNAi not only requires innovation in the lab - it requires innovation in how we make our medicines. Read More ›

Subscribe to siRNA

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site